TScan Therapeutics
TCRX
TCRX
24 hedge funds and large institutions have $30.4M invested in TScan Therapeutics in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
4% less funds holding
Funds holding: 25 → 24 (-1)
14% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 7
Holders
24
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$4.28M | |
| 2 | +$1.72M | |
| 3 | +$782K | |
| 4 |
Morgan Stanley
New York
|
+$56.8K |
| 5 |
LPL Financial
San Diego,
California
|
+$50K |
Top Sellers
| 1 | -$2.86M | |
| 2 | -$1.88M | |
| 3 | -$445K | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$168K |
| 5 |
Renaissance Technologies
New York
|
-$37K |